ID Fund
Angela is an experienced executive, advisor and serial entrepreneur with a 25-year track record of founding and building disruptive, technology-based products and companies across a range of diverse global industries, including e-mobiilty, biotech/medtech, consumer health, technology, software and transportation & logistics. She is a named inventor on 7 issued patents. She is presently the founder and managing director of Strand Strategy, a boutique technology advisory firm and founder and CEO of Cliffdive Records. Formerly, Angela served in leadership, director and executive roles for multiple public companies and growth-stage companies that had subsequent successful exits including Aerogen (acquired by Nektar Therapeutics, NASDAQ:NKTR), Novacept (acquired by Cytyc, NASDAQ: CYTC, now NASDAQ: HOLX) and FemRx (acquired by J&J). Strand previously worked for Baxter Healthcare, Federal Express and IBM. She holds a B.S. in communications and an M.B.A. in marketing from the University of Tennessee.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
ID Fund
4 followers
ID Fund is a by-invitation only venture capital and private equity investment company. ID Fund seeks investments in high quality late stage companies with imminent exits (IPO or sale) which are expected within 18-24 months. ID Fund’s investors including ultra-high net worth individuals, family offices, institutions and non-U.S. investors.